Efficient induction of protective anti-malaria immunity by recombinant adenovirus

Vaccine

Volumn 16, Issue 19, 1998, Pages 1812-1817

  Rodrigues, Elaine G ^a   Zavala, Fidel ^a   Nussenzweig, Ruth S ^a   Wilson, James M ^b   Tsuji, Moriya ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adenovirus; Malaria; Protection

Indexed keywords

MALARIA VACCINE; PROTOZOAL PROTEIN;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; CELLULAR IMMUNITY; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; IMMUNIZATION; IMMUNOGENICITY; MALARIA; MALARIA CONTROL; MOUSE; NONHUMAN; PLASMODIUM YOELII; PRIORITY JOURNAL; SPOROZOITE; SUBCUTANEOUS DRUG ADMINISTRATION; VIRUS RECOMBINANT;

ADENOVIRIDAE; AMINO ACID SEQUENCE; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; LIVER; LYMPHOCYTE ACTIVATION; MALARIA; MALARIA VACCINES; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PLASMODIUM YOELII; PROTOZOAN PROTEINS;

EID: 0032210888     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00181-9     Document Type: Conference Paper

References (27)

1. 1 Nardin, E.H. and Nussenzweig, R.S. T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages. Annu. Rev. Immunol. 1993, 11, 687-727.
2. 2 Schofield, L., Villaquiran, J., Ferreira, A., Schellekens, H., Nussenzweig, R. and Nussenzweig, V. Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature 1987, 330, 664-666.
3. 3 Weiss, W.R., Sedegah, M., Beaudoin, R.L., Miller, L.H. and Good, M.F. CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 573-576.
4. 4 Romero, P., Mariyanski, J.L., Corradin, G.P., Nussenzweig, R.S., Nussenzweig, V. and Zavala, F. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 1989, 341, 323-326.
5. 5 Rodrigues, M.M., Cordey, A.S. and Arreaza, G. et al. CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria. Int. Immunol. 1991, 3, 579-585.
6. 6 Khusmith, S., Sedegah, M. and Hoffman, S.L. Complete protection against Plasmodium yoelii by adoptive transfer of a CD8+ cytotoxic T-cell clone recognizing sporozoite surface protein 2. Infect. Immun. 1994, 62, 2979-2983.
7. 7 Renia, L., Grillot, D. and Marussig, M. et al. Effector functions of circumsporozoite peptide-primed CD4+ T cell clones against Plasmodium yoelii liver stages. J. Immunol. 1993, 150, 1471-1478.
8. 8 Takita-Sonoda, Y., Tsuji, M., Kamboj, K., Nussenzweig, R.S., Clavijo, P. and Zavala, F. Plasmodium yoelii: peptide immunization induces protective CD4+ T cells against a previously unrecognized cryptic epitope of the circumsporozoite protein. Exp. Parasitol. 1996, 84, 223-230.
9. 9 Tsuji, M., Romero, P., Nussenzweig, R.S. and Zavala, F. CD4+ cytolytic T cell clone confers protection against murine malaria. J. Exp. Med. 1990, 172, 1353-1357.
10. 10 Imler, J.L. Adenovirus vectors as recombinant viral vaccines. Vaccine 1995, 13, 1143-1151.
11. 11 Kumar, S., Miller, L. and Quakyi, I. et al. Cytotoxic T cells specific for the circumsporozoite protein of Plasmodium falciparum. Nature 1988, 334, 258-260.
12. 12 Aggarwal, A., Kumar, S., Jaffe, R., Hone, D., Gross, M. and Sadoff, J. Oral Salmonella: malaria circumsporozoite recombinants induce specific CD8+ cytotoxic T cells. J. Exp. Med. 1990, 172, 1083-1090.
13. 13 Li, S., Rodrigues, M.M. and Rodriguez, D. et al. Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 5214-5218.
14. 14 Graham, F.L., Prevec, L. Adenovirus-based expression vectors and recombinant vaccines. In: Ellis, R. W. (Ed.), Vaccines. New Approaches to Immunological Problems. Butterworth-Heinemann, USA, 1992, pp. 363-389.
15. 15 Crystal, R.G. Transfer of genes to humans: early lessons and obstacles to success. Science 1995, 270, 404-410.
16. 16 Top, F.H. Jr., Buescher, E.L., Bancroft, W.H. and Russell, P.K. Immunization with live type 7 and 4 vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans. J. Infect. Dis. 1971, 124, 155-160.
17. 17 Top, F.H. Jr. Control of adenovirus acute respiratory disease in U.S. Army trainees. Yale J. Biol. Med. 1975, 48, 185-195.
18. 18 Chaloner-Larsson, G., Contrearas, G. and Furesz, J. Immunization of Canadian Armed Forces personnel with live types 4 and 7 adenovirus vaccines. Can. J. Public Health 1986, 77, 367-370.
19. 19 Rodrigues, E.G., Zavala, F., Eichinger, D., Wilson, J.M. and Tsuji, M. Single immunizing dose of recombinant adenovirus efficiently induces CD8+ T cell-mediated protective immunity against malaria. J. Immunol. 1997, 158, 1268-1274.
20. 20 Davidson, B.L., Allen, E.D., Kozarsky, K.F., Wilson, J.M. and Roessler, B.J. A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nature Genet. 1993, 3, 219-223.
21. 21 Yang, Y., Nunes, F.A., Berencsi, K., Furth, E.E., Gonczol, E. and Wilson, J.M. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 4407-4411.
22. 22 Miyahira, Y., Murata, K. and Rodriguez, D. et al. Quantification of antigen-specific CD8+ T cells using an ELISPOT assay. J. Immunol. Meth. 1995, 181, 45-54.
23. 23 Briones, M.R. S., Tsuji, M. and Nussenzweig, V. The large difference in infectivity for mice of Plasmodium berghei and Plasmodium yoelii sporozoites cannot be correlated with their ability to enter into hepatocytes. Mol. Biol. Parasitol. 1996, 77, 7-17.
24. 24 Chomczynski, P. and Sacchi, N. Single -tep method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987, 162, 156-159.
25. 25 Sedegah, M., Hedstrom, R., Hobart, P. and Hoffman, S.L. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 9866-9870.
26. 26 Nussenzweig, V. and Nussenzweig, R.S. Rationale for the development of an engineered sporozoite malaria vaccine. Adv. Immunol. 1989, 45, 283-334.
27. 27 Rodrigues, M., Nussenzeig, R.S. and Zavala, F. The relative contribution of antibodies, CD4+ and CD8+ T cells to sporozoite-induced protection against malaria. Immunology 1993, 80, 1-5.